Advertisement

CHEST: Mortality Down With GLP-1 Receptor Agonist Use in T2D, Especially in Those With...

0

20 percent greater mortality benefit seen in obstructive sleep apnea population

Deep Sedation in ICU Linked to Loss of Independent Living

0

High proportion of time in deep sedation linked to loss of independent living among patients who lived independently before ICU admission

CHEST: SGLT2 Inhibitors May Slow Nodule Growth in Pulmonary Malignancies

0

Patients prescribed SGLT2 inhibitors less likely to exhibit nodule growth and to undergo a surgical intervention

World Trade Center Toxic Exposure Tied to Higher Risk for Lung Cancer

0

Greater exposure from Sept. 11, 2001, attacks tied to three times higher rate of disease incidence

Inhaler-Related Emissions Increased 24 Percent From 2014 to 2024

0

87 percent of total emissions were accounted for by albuterol, budesonide-formoterol, fluticasone propionate inhalers

FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

0

Twice-daily oral tablet marks first approval of idiopathic pulmonary fibrosis in more than 10 years

Medicaid Expansion Can Improve Five-Year Survival in Cancer

0

Improvements in cause-specific and overall survival seen for those residing in rural and high-poverty communities

Sotatercept Reduces Risk for Clinical Worsening in Adults With Recently Diagnosed PAH

0

Benefit with sotatercept seen among adults with pulmonary arterial hypertension diagnosed less than a year earlier

Rates of Physician Attrition From Clinical Practice Have Risen Since 2013

0

Rates of attrition up for male and female physicians, in rural and urban settings, across specialties, across geographic regions

Budesonide-Formoterol More Effective Than Salbutamol for Preventing Asthma Attacks in Children

0

Similar safety profile seen in children with mild asthma aged 5 to 15 years